WO2009063443A2 - Medical system, apparatus and method - Google Patents
Medical system, apparatus and method Download PDFInfo
- Publication number
- WO2009063443A2 WO2009063443A2 PCT/IL2007/001393 IL2007001393W WO2009063443A2 WO 2009063443 A2 WO2009063443 A2 WO 2009063443A2 IL 2007001393 W IL2007001393 W IL 2007001393W WO 2009063443 A2 WO2009063443 A2 WO 2009063443A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- patient
- medical
- index
- value
- condition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/0205—Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/0816—Measuring devices for examining respiratory frequency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/083—Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
- A61B5/0833—Measuring rate of oxygen consumption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/083—Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption
- A61B5/0836—Measuring rate of CO2 production
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/024—Measuring pulse rate or heart rate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/091—Measuring volume of inspired or expired gases, e.g. to determine lung capacity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Clinical applications
- A61B8/0883—Clinical applications for diagnosis of the heart
Definitions
- Medical monitoring devices are routinely used in various medical settings to provide crucial data regarding a patient's medical condition.
- the monitoring devices may be divided into two main groups: monitoring devices that are used to monitor parameters that are a direct measure of one of the patient's physiological functions and monitor device that are used to monitor parameters that are an indirect measure of the status of a physiological function.
- a parameter that is a direct measure for a physiological function is capnography that may be used to measure and provides values of the CO 2 concentration in the ventilated breath, which is a direct measure of the patients ventilation functioning.
- a parameter that is an indirect measurement is blood pressure, which indirectly provides information regarding the functioning of the heart and the cardio vascular condition of the patient.
- Capnography is a non-invasive monitoring method used to continuously measure CO 2 concentration in exhaled breath.
- the CO 2 which is a constant metabolism product of the cells, is exhaled out of the body and the concentration of the exhaled CO 2 , also known as end tidal CO 2 (EtCO 2 ) is an approximate estimation of the arterial levels of CO 2 .
- the measurements of the CO 2 concentration in a breath cycle are performed by a capnograph and the results are a numerical value displayed also in a graphical format in the shape of a waveform named a capnogram.
- the numerical value of the results may be presented in units of pressure (mm Hg) or percentile.
- the capnogram may depict CO 2 concentration against total expired volume, but the more common capnogram illustrates CO 2 concentration against time.
- Analyzing the capnogram may yield valuable information about the patient's clinical status.
- Normal capnogram exhibits one or more typical waveforms, each one represents a single respiratory cycle and deviation from the normal waveform may hint as to the clinical situation of the patient.
- an abnormally high basal line represents re-breathing of exhaled CO 2 ; a slow increase in CO 2 concentration may hint to uneven emptying of the lungs; rising in CO 2 concentration without reaching a plateau may hint to situations of asthma or other lower airway obstruction, very small changes in CO 2 concentration may indicate an apnea situation, and the like.
- a trend display is also available in which many individual consecutive breath cycles are compressed together so that changes over time may be easily distinguished, providing yet an additional aid in assessing and monitoring the patient's ventilation and clinical profile.
- Capnography is widely used today as an important tool for tracking patient's ventilation status in various health care settings, such as Emergency Room (ER), Operation Room (OR), Intensive Care Unit (ICU) and Emergency Medical Services (EMS).
- ER Emergency Room
- OR Operation Room
- ICU Intensive Care Unit
- EMS Emergency Medical Services
- Cardiovascular for example in CPR, shock, pulmonary embolism
- Respiratory for example, verification of endotracheal tubing, mechanically ventilated patients, conditions such as Asthma, hyperventilation, hypoventilation, apnea; Sedation (for example during operation); Patient transport (both intra- and inter- hospital).
- various other parameters may be indicative (directly or indirectly) of the ventilation (respiratory) status of a patient.
- Such parameters may include, for example, saturation of oxygen in the blood cells and other organs, heart rate, respiration rate, breath flow rate, blood pressure, and the like. Combination of various parameters may yield an improved indication clinical condition of the patient in general and of the ventilatory status of the patient in particular.
- a medical monitoring device that includes one or more sensors, wherein a sensor is adapted to sense at least one parameter of a patient and computator adapted to receive an output of at least one sensor and to compute an index- value directly related to a condition of the patient.
- the parameter of a patient may include a respiratory related parameter, pulmonary related parameter, cardiac related parameter or any combination thereof.
- the parameter of a patient may include respiration rate, EtCO 2 , SpO 2 , heart rate, or any combination thereof.
- the one or more sensors may include a capnograph, pulse oximeter, heart rate monitor, or any combination thereof.
- the index value may be in the range of 1 to 10.
- An increase in the index value may be indicative of an improvement in a patient's condition.
- a decrease in the index value may be indicative of a deterioration of a patient's condition.
- the device computator may be adapted to compute the index value according to an average of an output of at least one sensor.
- the computator may further be adapted to compute the index-value according to a medical significance of an output of at least one sensor, wherein the medical significance may be determined by correlating the output value of the sensor and the ordinary level of a medical condition.
- the device may be further adapted to compute a trend of the index- value.
- the device may be further adapted to compute a reliability index of the index- value.
- the device may additionally be adapted compute a pause frequency parameter.
- the device may further be adapted to provide medical recommendation.
- the medical recommendation may be determined according to the index value.
- the medical recommendation may be determined according to the index value and a parameter related to a CO 2 waveform.
- the device may further include a user interface.
- the device may also include a graphic display of the index value.
- the device may also provide indication correlating to a condition of the patient.
- the condition may include hyperventilation, hypoventilation or both.
- the device may further display sub regions of the index value, wherein the sub regions correlate to a condition of the patient.
- a method for computing an index- value directly related to a condition of the patient includes: a medical monitoring device comprising one or more sensors, wherein a sensor is adapted to sense at least one parameter of a patient and a computator adapted to receive an output of at least one sensor and compute said index value.
- the at least one parameter of a patient may include a respiratory related parameter, pulmonary related parameter, cardiac related parameter and or combination thereof.
- the parameter of a patient may include respiration rate, EtCO2, SpO2, heart rate, or any combination thereof.
- the one or more sensors may include a capnograph, pulse oximeter, heart rate monitor, or any combination thereof.
- the index value may be in the range of 1 to 10.
- An increase in the index value may be indicative of an improvement in a patient's condition.
- a decrease in the index value may be indicative of a deterioration of a patient's condition.
- the device computator may adapted to compute the index value according to an average of an output of at least one sensor.
- the computator may further be adapted to compute the index-value according to a medical significance of an output of at least one sensor, wherein the medical significance may be determined by correlating the output value of the sensor and the ordinary level of a medical condition.
- the device of the method may be further adapted to compute a trend of the index- value.
- the device may be further adapted to compute a reliability index of the index-value.
- the device may additionally be adapted compute a pause frequency parameter.
- the device of the method may further be adapted to provide medical recommendation.
- the medical recommendation may be determined according to the index value.
- the medical recommendation may be determined according to the index value and a parameter related to a CO 2 waveform.
- the device of the method may further include a user interface.
- the device may also display of the index value.
- the device may also provide indication correlating to a condition of the patient.
- the condition may include hyperventilation, hypoventilation or both.
- the device may further display sub regions of the index value, wherein the sub regions correlate to a condition of the patient.
- a medical system that includes a monitoring device comprising one or more sensors, wherein a sensor is adapted to sense at least one parameter of a patient, computator adapted to receive an output of at least one sensor and to compute an index-value directly related to a condition of the patient and a sampling unit adapted to sample breath from a patient.
- the sampling unit of the medical system may include an oral nasal cannula.
- the parameter of a patient may include a respiratory related parameter, pulmonary related parameter, cardiac related parameter or any combination thereof.
- the parameter of a patient may include respiration rate, EtCO2, SpO2, heart rate, or any combination thereof.
- the one or more sensors may include a capnograph, pulse oximeter, heart rate monitor, or any combination thereof
- the index value may be in the range of 1 to 10.
- An increase in the index value is indicative of an improvement in a patient's condition.
- a decrease in said index value is indicative of a deterioration of a patient's condition.
- Fig. IA- A graph depicting the CO 2 medical significance level
- Fig. IB A graph depicting the respiration rate medical significance level
- Fig. IC- A graph depicting the SpC ⁇ medical significance level
- Fig. ID A graph depicting the heart rate medical significance level
- the terms “user”, “medical user” and “health care provider”, “health care professional” may interchangeably be used.
- the terms may include nay health care provider that may treat and/or attend to a patient.
- a user may include, for example, a nurse, respiratory therapist, physician, anesthesiologist, and the like.
- the terms “device”, “monitoring device” and “medical device” may interchangeably be used.
- the terms “patient”, subject” may interchangeably be used and may relate to a subject being monitored by any monitoring device for any physical-condition related parameter and/or health related parameter.
- condition-index-value and “index value” may interchangeably be used.
- patient related parameters are collected on line and may provide various health care providers, such as a nurse, a physician, a respiratory therapist, an anesthesiologist and the like, with information regarding the patient's status.
- the information routinely presented may include various types of information regarding various parameters that may be sensed by various sensors. Viewing and interpreting the information presented may sometimes be a cumbersome, complicated and time consuming task for the health care provider.
- the health care providers there is a need to analyze the various patient related parameters (data) that are collected on line, in real time, and provide the health care providers with a more comprehensible, meaningful, intuitive, clearer and useful information about the patient status.
- the data collected may be calculated and the information to the health care provider may be provided in the form of a condition- index-value that is directly related to the clinical condition of the patient.
- the condition-index-value may be calculated based upon various parameters of a patient that may be sensed/measured by appropriate sensors. Providing the condition-index value to the health care provider may result in a clear indication for the health care provider to realize when more medical attention is required for a given patient and for a given patient condition.
- condition-index-value may be calculated/computed by a device, such as, for example, a monitoring device.
- the monitoring device may include one or more sensors that may be used to sense and/or measure, and/or calculate various health related parameters.
- the monitoring device may include any known medical monitoring device, such as, for example, capnograph, oxymeter, spirometer, heart rate sensors, blood pressure sensors, ECG, EEG, Ultrasound, and the like, and any combination thereof.
- the device may calculate the condition-index-value, and display the index alone or in combination with the various patient parameters that may be sensed/measured by appropriate sensors.
- the device may also provide medical recommendations to the user based on the analysis of the collected patient data.
- the device may track and notify the health care provider regarding changes over time of the patient condition. For example, the device may notify the health care provider if the patient condition is stable, improving or deteriorating.
- condition-index-value may be a unit-less value in any predetermined range, such as, for example, in the range of 1 to 100.
- condition-index- value may in the range of 1 to 10, wherein 10 indicates the best condition, and 1 indicates the worst condition..
- sub ranges may be assigned. For example, a sub-range from 8 to 10 indicative of a stable, normal condition, where no intervention is needed.
- a sub-range of 6-7 may be indicative for the health care provider that more attention is needed patient re-evaluation is recommended.
- a sub range of below 5 may indicate to the health care provider that intervention is needed and patient re-evaluation may be necessary.
- condition-index-value may be assigned different graphical signs, when displayed to the health care provider.
- the different graphical signs may include, for example, different colors, different units, different letters, and the like.
- the value may be colored green
- condition-index-value in the sub-range of 5 to 7 the value may be colored yellow
- condition-index-value in the subrange of below 5 value may be colored red.
- various other visual indicators may also be used to indicate changes that may be correlated with known physical conditions, such as for example, up and down arrows that may indicate, for example an increase or decrease, respectively, in one or more measured parameters.
- condition index value may be calculated by various means, such as, for example by use of mathematical equations, algorithms, formulas, and the like that may take into consideration one or more of the values or derivatives of the values of the parameters that are being measured by the monitoring device.
- condition-index-value trend may be displayed graphically.
- the graphic display may exhibit the condition-index- value trended over the last "n" (time units) of monitoring.
- n may be any time period in the range of 5 minutes to 12 hours.
- This display may be used to indicate the patient's status, such as, for example: stable, improving, deteriorating, as well as providing a depiction of the rate and change of the patient's status.
- Displaying of the condition- index- value trend may simplify the assessment of the changes in the condition of the patient as compared to assessing the patient condition based on the trend of the individual parameters
- it may not be easy and intuitive to determine the patients status and change in status, without taking into consideration the absolute values of the individual parameters and their interactions.
- condition-index-value trend may be depicted as a graphic display of the condition-index- value over time.
- the duration period of the trend may be chosen to be over any time period in the range of, for example between 5 minutes to 12 hours of the last measurements.
- the resolution of the graphical display may change accordingly in correlation to the selected time period.
- an index of reliability (referred to herein also as “reliability index” “RI”) may also be determined.
- the index of reliability (referred to herein also as “reliability index” or “RI”) may provide a measure of the reliability of the data and more specifically, the reliability of the condition-index- value.
- the reliability index may be used to predict and anticipate artifacts.
- the reliability index may be determined, for example, by analysis of the CO 2 waveforms, as depicted by a capnogram. If breath flow is also measured, its waveforms may also be used for this purpose. The use of breath flow measurements may refine and improve the index of reliability.
- Breath flow waveforms strongly complement the waveforms created by the CO 2 measurement, since both measurements represent essentially the same event, which is the breath cycle. While the breath flow relates to the envelope of the waveform, the CO 2 relates to the CO 2 concentration within the envelope. Using both parameters may better reveal and uncover what is a measurement noise, artifact, and the like.
- a pause frequency parameter may be determined. This parameter may include a measure of events wherein no breathing is detected, over a period of time.
- the events of lack of breathing may include, for example pause and apnea events, and the pause frequency parameter may include a measure of patient's pause and apnea events over a period of time.
- the pause frequency parameter may be calculated from the CO 2 waveform, as obtained by the capnogram.
- a pause event may be defined, for example, as any inhalation stage that persists for longer than any number of seconds in the range of, for example, 5 to 40 seconds (such as for example 20 seconds), and proceeds after an exhalation period lasting less than any number of seconds in the range of, for example, 5 to 20 seconds (such as, for example, 10 seconds).
- the time periods may be determined, for example, according to the average time of the last three exhalation cycles. Such determination of a pause event may be used to exclude a slow, rhythmic breathing pattern from being defined as a group of pause events. In addition, a maximum time out of, for example, 100 seconds may be determined.
- the Pause Frequency Parameter may be defined by the number of pause events per period of time (such as for example, an hour).
- the pause frequency may be updated at any time intervals, such as for example, every 5 minutes, after the period of 1 hour.
- the values of the pause frequency may further be stored and used for the display of the pause frequency trend, wherein the trend data represent the change of the pause frequency over time.
- a value may be provided and updated, for example, every 15 minutes until 1 hour has been reached (wherein during this time period the frequency is calculated as if it was calculated for 1 hour).
- an indication showing that the pause frequency is still based on a shorter period than 1 hour may be displayed.
- the health care provider such as a nurse
- the pause amplitude parameter may also be determined.
- the pause amplitude parameter may be determined by measurements of the time length (such as, for example, in the range of 5 to 60 seconds) of each of the detected pause events and the dispersion of the time lengths of the pause events over a period of time (such as, for example, over a time period of 60 minutes).
- the device may further include and display medical recommendations to the health care professionals.
- the medical recommendations may be deduced from analysis of at least some of the individual parameter values and patterns and comparison of the measured values and patterns to the known ranges and patterns of the individual parameters. These recommendations may be displayed in addition to the indications derived from the calculated condition- index-value.
- the medical device may include a user interface that may allow the user to select the data to be displayed and to control various operating parameters.
- different displays may be included to accommodate different needs of the different users (such as a nurse, a physician, an anesthesiologist, and the like). Allowing the user to change the view of the data may permit the user to toggle through the different levels of information for further evaluation of a condition.
- the basic screen may be display the condition- index-value and the condition-index-value trend data. Changing to the next display may reveal the actual (measured) data values and the trends of the values that relate to the parameters from which the condition-index-value is calculated. Further toggling the display may provide the pause frequency and other related analysis and calculation.
- the use of the various displays may also allow the user to focus on the parameters that caused an indication of an event and/or recommendation to the user.
- the user interface may also allow the user to enter information that is characteristic for each patient.
- characteristic patient information is necessary to allow accuracy of the various measurements and calculations.
- Such information may include, for example age, weight, height, sex, and the like, of the specific patient.
- classification detection means of various patients may be utilized, wherein the classification may be based on parameters such as, for example, age group, weight group, sex, and the like. Using such classification may allow the monitoring device to correct its settings to be appropriate for that relevant patient type and environment.
- the condition-index-value may represent the respiratory status and/or the pulmonary status and/or the cardiac status of the patient. This may be accomplished by providing an index value that is calculated based upon various respiratory, pulmonary and cardiac parameters, such as, for example, but not limited to: EtCO 2 , respiratory rate, breath flow rate, spirometry readings, , O 2 saturation, SpO 2 , blood pressure, blood gases, heart rate, Electrocardiogram (ECG), Electroencephalogram (EEG), Ultrasound measurements, such as heart echogram, and the like and any combination thereof.
- EtC02 relates to End tidal CO2.
- the CO 2 is exhaled out of the body and the concentration of the exhaled CO 2 , also known as end tidal CO 2 (EtCO 2 ) is an approximate estimation of the alveolar CO 2 pressure and thus of the arterial levels of CO 2 .
- the measurements of the CO 2 concentration in a breath cycle are performed by a capnograph and the results are a numerical value displayed also in a graphical format in the shape of a waveform named a capnogram.
- the values of EtC02 may be measured in units of pressure, such as, for example, mrnHg.
- the term SpO2 relates to the saturation of peripheral oxygen. It is a measurement of the amount of oxygen attached to the hemoglobin in red blood cell in the circulatory system. SpO2 values are generally given as a percentage (for example, normal value is above 96%). SpO2 may be monitored and measured by various monitors, such as for example, Pulse Oximeter.
- the term Respiration Rate (RR) is defined as the number of breaths taken in a minute and it may change under various physiological and medical conditions. The rate may be abnormally high (tachypnea), abnormally low (bradypnea) or non-existent (apnea).
- Heart Rate relates to the number of heart pulses (beats) in a minute.
- hypoventilation relates to a state of respiratory depression that may occur when ventilation is inadequate to perform needed gas exchange. Hypoventilation may cause an increased concentration of carbon dioxide and respiratory acidosis. Hypoventilation may be caused by various medical conditions and/or by use of some drugs and medicines.
- hypoventilation relates to a state of breathing faster and/or deeper than necessary, thereby reducing the carbon dioxide concentration of the blood below normal.
- the condition-index-value may be a Pulmonary/Respiratory Index value (also referred to herein as "PI") may be determined.
- the PI index may represent a measurement of the patient's respiratory status. It may be deduced from various measured parameters, such as, for example: EtCO 2 , Respiration Rate, SpO 2 and Heart Rate.
- the PI may be indicative of the absolute patient condition.
- the PI may be a unit-less value in the range of 1 to 10, wherein 10 indicates the best condition, and 1 indicate the worst condition. Within the range of 1 to 10, sub ranges (subdivisions) may be assigned. For example, a subrange from 8 to 10 indicative of a stable, normal condition, where no intervention is needed.
- a sub-range of 6-7 may be indicative for the health care provider that more attention is needed.
- a sub range of below 5 may indicate to the health care provider that intervention and/or patient re-evaluation and/or change in therapy is recommended.
- the various sub-ranges of the condition-index- value may be assigned different graphical signs, when displayed to the health care provider.
- the different graphical signs may include, for example, different colors, different units, different letters, and the like.
- the value may be colored green
- condition-index- value in the sub-range of 5 to 7 the value may be colored yellow and for condition-index- value in the subrange of below 5, value may be colored red.
- various other visual indicators may also be used to indicate changes that may be correlated with known medical conditions, such as for example, up and down arrows that may indicate, for example a state of hyperventilation and hypoventilation, respectively.
- the PI index value may be determined by various ways, using various calculation methods and various algorithms, as further detailed below herein.
- the PI may be deduced from various parameters and may be assigned the highest value, for example "10", when the individual values of the various parameters are well within their respective normal ranges.
- the PI value may decrease below "10” when the value of one or more of the individual parameters changes from the normal respective ranges for those parameters. The decrease of the PI value may be sharper when several individual parameters change together.
- the PI value may be updated continuously and it may be calculated from an average of the values of the parameters that are used to produce the PI value.
- the averaging time used for the determination of the PI value may also be adaptive. For example, if there is an erratic measurement, the average time may increase. The erratic characteristics used for deciding the averaging time may result, for example, from the respiratory rate values, the CO 2 waveform, and any other suitable parameter that is used for the calculation of the PI.
- the PI value may also be indicative of conditions such as hypoventilation and hyperventilation.
- an appropriate additional indicative signaling may be displayed, such as, for example an upward arrow (indicative of hyperventilation) and downward arrow (indicative of hypoventilation).
- the decision as to whether the patient's status is in either hypoventilation or hyperventilation may be based for example, upon the Respiratory Rate, when respiratory rate is one of the measured parameters.
- the PI value there are various methods to calculate the PI value.
- various parameters may be measured and used for the calculation of the PI value.
- the PI may be calculated based on measuring the values of at least one of the parameters EtCO 2 , Respiration Rate, SpO 2 and Heart Rate. The real time values of these parameters may be measured continuously.
- an adaptive running average may be collected for all the 4 measured parameters (average EtCO 2 , average respiratory rate, average heart rate and average SpO 2 ). This adaptive running average may be calculated by collecting the data displayed by the monitors that measure the parameters, each second, and averaging over a period of time (as explained below).
- the averaging time period may be calculated and defined using an adaptive type algorithm.
- the default time period may be in the range of 5 to 60 seconds, such as for example, 30 seconds.
- the time may increase in steps of, for example, 2 to 30 seconds, such as, for example, in steps of 15 seconds; and the maximum period of time may be in the range of 5 to 180 seconds, such as, for example, 90 seconds, 120 seconds, and the like.
- the parameter value of respiratory rate may be used.
- the standard deviation of the respiratory rate over the last predetermined period of time (such as, for example, 30 seconds) may be continuously measured. If the standard deviation of the respiratory rate value is below a predefined threshold, then the averaging period does not change. If the standard deviation of the respiratory rate over the last predetermined period of time is above the predetermined threshold, then the averaging period may be increased (for example, by 15 seconds).
- the PI may be calculated by using mathematic calculations.
- the calculation may be based on the measuring the values of at least one of the parameters EtCO 2 , Respiration Rate (RR), SpO 2 and Heart Rate (HR) and the calculated average of those parameters, as detailed above herein.
- the calculations may relay on known defined ranges values for each of the measured parameters (in correlation with the patient characteristics, as detailed below). Meeting predefined conditions of the various measured parameters values result in an appropriate calculated PI value.
- the PI may be calculated by using mathematic calculations.
- the calculations may be based on multiplication of the medical significance level (risk/probability level) that is associated with each of the measured parameters.
- the medical significance level of each of the measured parameters may be determined by creating a graph, indexing tables, and the like, which correlate the value of the parameter with an ordinary (standard/typical, common/normal) level of a physical condition, such as, for example ventilatory condition (such as breathing, respiration, exhaling, inhaling).
- the ordinary level of the physical condition may be in the range of 0 to 1, wherein 1 signifies the best physical condition and 0 signifies the worse physical condition.
- Fig. IA illustrates a graph which depicts the medical significance (risk levels) of the EtCO 2 parameter.
- the Y-axis is the ordinary level, in the scale of 0 to 1.
- the X-axis is the level of EtCO 2 in units of rnriiHg.
- the medical significance curve depicts the correlation curve between the ordinary level and the level of EtCO 2 and the calculated curve that best correlates to the medical significance curve.
- Fig. IA 8E-06x3 - 0.0015x2 + 0.0724x - 0.0496.
- Fig. IB illustrates an exemplary graph which depicts the medical significance levels of the respiration rate parameter. As shown in Fig. IB, the Y-axis is the ordinary level, in a scale of 0 to 1.
- the X-axis is the respiratory rate in units of number of breaths in a minute.
- the medical significance curve depicts the correlation curve between the ordinary level and respiratory rate and the calculated curve that best correlates to the medical significance curve.
- Fig. 1C illustrates an exemplary graph which depicts the medical significance levels of the SpO 2 parameter. As shown in Fig. 1C, the Y- axis is the ordinary level, in a scale of 0 to 1. The X-axis is the SpO 2 percentile.
- the medical significance curve depicts the correlation curve between the ordinary level and the SpO 2 and the calculated curve that best correlates to the medical significance curve.
- Fig. ID illustrates an exemplary graph which depicts the medical significance levels of the heart rate parameter. As shown in Fig. ID, the Y-axis is the ordinary level, in a scale of 0 to 1. The X-axis is the heart rate that is measured in number of beats in a minute.
- the medical significance curve depicts the correlation curve between the ordinary level and the heart rate and the calculated curve that best correlates to the medical significance curve.
- Y 4 8E-07x3 - 0.0003x2 + 0.0406x - 0.4389.
- indexing tables may also be used to correlate between the ordinary level and the value of each of the measured parameters.
- the PI may be calculated by multiplying the medical significance factors of each of the measured parameters, obtained by the equations detailed above herein, and multiplying the result by 10, to get an IP value in the range of 1 tolO.
- the HR medical significance value (Y 4 ) is introduced to the calculations, only if the medical significance value of one of the other parameters is less than 0.8.
- the equations presented above herein are valid up to the following maximal values of the individual parameters: the EtCO 2 value reaches a value of about 90rnrnHg, the respiratory rate reaches a value of about 50bpm and SpO 2 reaches 50%.
- an upward arrow indication may be included if the respiration rate is greater than a predetermined number of beats per minute (BPM), such as, for example, 24 BPM.
- BPM beats per minute
- a downward arrow indication may be included if the respiration rate is below a predetermined number of BPM, such as, for example, 12 BPM. If the respiration rate is within a predetermined range, such as, for example between 12 and 24 BPM, no arrow indication is provided.
- the change of the PI value over time may be displayed graphically.
- the graphic display may exhibit the PI trended over the last "n" (time units) of monitoring.
- n may be any time period in the range of 5 minutes to 12 hours.
- This display may be used to indicate the patient's status, such as, for example: stable, improving, deteriorating, as well as providing a depiction of the rate and change of the patient's status.
- Displaying of the PI trend may simplify the assessment of the changes in the ventilatory condition of the patient as compared to assessing the patient condition based on the trend of the individual parameters
- it may not be easy and intuitive to determine the patients status and change in status, without taking into consideration the absolute values of the individual parameters and their interactions, since both an increase or decrease in any of those parameters may be "good” (improvement) or "bad” (deterioration), depending on the absolute value of the parameter. For example, a decrease from a higher than normal absolute value towards the normal absolute value may be considered “good”, while a decrease from a normal value to a lower than normal value may be considered "bad".
- the PI trend may be depicted as a graphic display of the PI values over time.
- the duration period of the trend may be chosen to be over any time period in the range of, for example between 5 minutes to 12 hours of the last measurements.
- the resolution of the graphical display may change accordingly in correlation to the selected time period.
- an index of reliability may also be determined.
- the index of reliability (referred to herein also as “reliability index” or “RI”) may provide a measure of the reliability of the data and more specifically, the reliability of the PI.
- the reliability index may be used to predict and anticipate artifacts.
- the reliability index may be determined, for example, by analysis of the CO 2 waveforms, as depicted by a capnogram. If breath flow is also measured, its waveforms may also be used for this purpose. The use of breath flow measurements may refine and improve the index of reliability. Breath flow waveforms strongly complement the waveforms created by the CO 2 measurement, since both measurements represent essentially the same event which is the breath cycle.
- the CO 2 relates to the CO 2 concentration within the envelope.
- the reliability index may assist the user (the health care provider) to decide if a low PI value or any of the other measured values is real (and represent a genuine clinical event), transient or an artifact.
- the reliability index may further assist the health care provider in assessing how much credibility may be attribute to the displayed PI value.
- the reliability index may allow the health care provider to detect artifacts, such as when the monitoring device is not placed properly on the patient, the monitoring device is not measuring properly, and the like.
- the reliability index may be determined from both analysis of the CO 2 waveform and respiration rate pattern. By obtaining data from controlled studies, the characteristic patterns attributed to artifacts may be defined. Analysis of the real time waveform depicted by the monitoring device and comparison to the known artifact patterns may be used to calculate the reliability index.
- a pause frequency parameter may be determined.
- This parameter may include a measure of events wherein no breathing is detected, over a period of time.
- the events of lack of breathing may include, for example pause and apnea events
- the pause frequency parameter may include a measurement of the patient's pause and apnea events over a period of time.
- Very often patients may stop breathing for short periods of time either because of mechanical obstructions or sometimes because a central (brain) block.
- the pauses (apnea events) are periodic and their frequency may be indicative of the condition of the patient.
- the pause frequency parameter may be calculated from the CO 2 waveform, as obtained by the capnogram.
- a pause event may be defined, for example, as any inhalation stage that persists for longer than any number of seconds in the range of, for example, 5 to 40 seconds (such as for example 20 seconds), and proceeds after an exhalation period lasting less than any number of seconds in the range of, for example, 5 to 20 seconds (such as, for example, 10 seconds).
- the time periods may be determined, for example, according to the average time of the last three exhalation cycles. Such determination of a pause event may be used to exclude a slow, rhythmic breathing pattern from being defined as a group of pause events. In addition, a maximum time out of, for example, 100 seconds may be determined.
- the pause frequency parameter may be defined by the number of pause events per period of time (such as for example, an hour).
- the pause frequency may be updated at any time intervals, such as for example, every 5 minutes, after the period of 1 hour.
- the values of the pause frequency may further be stored and used for the display of the pause frequency trend, wherein the trend data represent the change of the pause frequency over time.
- a value may be provided and updated, for example, every 15 minutes until 1 hour has been reached (wherein during this time period the frequency is calculated as if it was calculated for 1 hour).
- an indication showing that the pause frequency is still based on a shorter period than 1 hour may be displayed.
- the health care provider such as a nurse
- the pause amplitude parameter may also be determined.
- the pause amplitude parameter may include the time length (such as, for example, in the range of 5 to 60 seconds) of each of the detected pause events and the dispersion of the time length of those pause events over a period of time (such as, for example, over a time period of 60 minutes).
- the monitoring device may further include and display medical recommendations to the health care professionals.
- the medical recommendations may be deduced from analysis of at least some of the individual parameters values and patterns and comparison of the measured values and patterns to the known ranges and patterns of the individual parameters. These recommendations may be displayed in addition to the indications derived from the calculated condition- index- value.
- the medical recommendations may be based on, for example, the characteristics of the CO 2 waveforms (presented as a capnogram) and RI values.
- the recommendation provided to the health care provider may include, for example such recommendation as: If CO 2 waveforms are observed with characteristics indicative of a partial obstruction (such as long downward slope of the waveform), then the device may recommend "open airway" or "check airway".
- the device monitor may recommend: "check blood pressure” or similar.
- the detection of known CO 2 waveform patterns which are indicative of known patient conditions that should and could be treated to improve the patient care, may be used in triggering and issuing the recommendations to the health care professional. For example, it is very common that a patient entering partial obstruction promote a waveform pattern wherein the downward slope of the capnogram increases in time, with a gradual fall. In such an instance, a notification to the health care provider, such as, "check patient airway" may be issued.
- lower airway obstruction may be seen by a capnogram showing a curved ascending phase and up-sloping alveolar plateau that indicate the presence of acute bronchospasm or obstructive lung disease;
- distinguishing between bradypneic hypoventilation from hyperventilation may be performed according to the CO2 wave form: while in the bradypneic hypoventilation decreased respiratory rate, high amplitude and wide capnogram are detected, in hyperventilation an increase in respiratory rate, low amplitude and narrow capnogram are detected.
- the medical device may further include a user interface that may allow the user to select the data to be displayed and to control various operating parameters.
- different displays may be included to accommodate different needs of the different users (such as a nurse, a physician, an anesthesiologist, and the like). Allowing the user to change the view of the data may permit the user to toggle through the different levels of information for further evaluation of a condition.
- the basic screen may be display the condition-index-value and the condition-index-value trend data. Changing to the next display may reveal the actual (measured) data values and the trends of the values that relate to the parameters from which the condition-index- value is calculated. Further toggling the display may provide the pause frequency and other related analysis and calculation.
- the use of the various displays may also allow the user to focus on the parameters that caused an indication of an event and/or recommendation to the user.
- the user interface may also allow the user to enter information that is characteristic for each patient.
- information may include, for example, age, weight, height, sex, and the like of the specific patient as well as other patient related information, such as, intubation (if the patient is intubated or not).
- intubation if the patient is intubated or not.
- the patient size and age may change the PI calculations: for an adult a respiration rate of 12 BPM would be normal, but 36BPM would be considered high, whereas for a child, respiration rate of 12 may be considered low, while 36BPM may be considered normal.
- classification detection means of various patients may be utilized, wherein the classification may be based on parameters such as, for example, age group, weight group, sex, intubation, and the like. Using such classification may allow the monitoring device to correct its settings to be appropriate for that relevant patient type and environment.
- the user interface may allow automatic detection of the type of the patient according to the measuring interface being used. For example, a tubing interface used to measure CO 2 in breath may be different between an adult and a child and accordingly, the user interface may automatically adjust the patient settings to match the patient size group.
- a medical device that may be used to monitor patient's health condition, such as respiratory and/or pulmonary and/or cardiac status.
- the device may include, for example a canpongraphy device that may be adapted to sense and/or obtain measurements of various parameters other than CO 2 .
- parameters may include, for example, O 2 levels, O 2 partial pressure, such as SpO2, heart rate, blood pressure, and the like.
- the device may further include a computator that may be used to receive information from at least one of the sensors and to compute a condition-index-value that is directly related to a condition of the patient.
- the condition index value may be in the range of 1 to 10, wherein 10 indicates the best condition while 1 indicates the worst condition.
- the monitoring device may further include one or display that may be used to present the data collected and calculated by the monitoring device.
- the display may present, for example, the calculated condition index in numerical format and in indexed format, wherein different ranges along the 1-10 scale of the calculated index may be assigned different colors; the change (trend) of the calculated condition index value • over time; the reliability of the calculated index value; values and patterns of the various parameters measured by the various sensors of the monitoring device; graphical indications regarding the status of the patient, such as, for example, downward and upward arrows; and the like.
- the monitoring device may further be adapted to issue medical recommendations based upon the calculated condition index value and other measured parameters.
- the monitoring device may include a user interface that may allow the user to input patient related data that is specific for the patient, such as, for example, age, sex, size of the patient.
- the user interface may further allow the user to choose the parameters to be displayed and the form in which the parameters may be displayed, such as for example in the form of graphs, numerical values, indicators, and the like.
- Example 1 Calculating PI value using mathematical methods As detailed above herein, any of the parameter values used for the calculation of the PI is based on the calculated value of the average EtCO 2 , average respiratory rate, average heart rate and average SpO 2 .
- EtCO 2 - End tidal CO 2 is measured in units of mmHg RR - Respiration Rate is measured in number of breaths per minute SpO 2 - is measured in percentile
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IL2007/001393 WO2009063443A2 (en) | 2007-11-13 | 2007-11-13 | Medical system, apparatus and method |
| EP07827366.1A EP2217141B1 (en) | 2007-11-13 | 2007-11-13 | Medical apparatus |
| US12/742,858 US8414488B2 (en) | 2007-11-13 | 2007-11-13 | Medical system, apparatus and method |
| JP2010533717A JP5443376B2 (ja) | 2007-11-13 | 2008-06-30 | 医療装置 |
| PCT/IL2008/000894 WO2009063446A2 (en) | 2007-11-13 | 2008-06-30 | Medical system, apparatus and method |
| EP18190608.2A EP3493216A1 (en) | 2007-11-13 | 2008-06-30 | Medical system, apparatus and method |
| EP08763650.2A EP2229641B1 (en) | 2007-11-13 | 2008-06-30 | Medical system, apparatus and method |
| US12/742,794 US8412655B2 (en) | 2007-11-13 | 2008-06-30 | Medical system, apparatus and method |
| IL205777A IL205777A (en) | 2007-11-13 | 2010-05-13 | Medical system, apparatus and method |
| IL205778A IL205778A (en) | 2007-11-13 | 2010-05-13 | Medical system |
| US13/336,652 US9533113B2 (en) | 2007-01-04 | 2011-12-23 | Integrated pulmonary index for weaning from mechanical ventilation |
| US13/831,721 US20130204099A1 (en) | 2007-11-13 | 2013-03-15 | Medical system, apparatus and method |
| IL227913A IL227913A0 (en) | 2007-11-13 | 2013-08-11 | Medical system, device and method |
| US15/208,190 US20160345843A1 (en) | 2007-11-13 | 2016-07-12 | Medical system, apparatus and method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IL2007/001393 WO2009063443A2 (en) | 2007-11-13 | 2007-11-13 | Medical system, apparatus and method |
Related Child Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/742,858 A-371-Of-International US8414488B2 (en) | 2007-11-13 | 2007-11-13 | Medical system, apparatus and method |
| PCT/IL2008/000894 Continuation-In-Part WO2009063446A2 (en) | 2007-01-04 | 2008-06-30 | Medical system, apparatus and method |
| US12/742,794 Continuation-In-Part US8412655B2 (en) | 2007-11-13 | 2008-06-30 | Medical system, apparatus and method |
| US13/831,721 Continuation US20130204099A1 (en) | 2007-11-13 | 2013-03-15 | Medical system, apparatus and method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2009063443A2 true WO2009063443A2 (en) | 2009-05-22 |
| WO2009063443A3 WO2009063443A3 (en) | 2009-09-03 |
Family
ID=40639254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IL2007/001393 Ceased WO2009063443A2 (en) | 2007-01-04 | 2007-11-13 | Medical system, apparatus and method |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US8414488B2 (https=) |
| EP (1) | EP2217141B1 (https=) |
| JP (1) | JP5443376B2 (https=) |
| IL (1) | IL205777A (https=) |
| WO (1) | WO2009063443A2 (https=) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012032501A1 (en) | 2010-09-10 | 2012-03-15 | Mila Group S.R.L. | Portable electromedical device |
| JP2015513724A (ja) * | 2012-02-17 | 2015-05-14 | コーニンクレッカ フィリップス エヌ ヴェ | 急性肺損傷(ali)/急性呼吸窮迫症候群(ards)アセスメント及びモニタリング |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8932227B2 (en) | 2000-07-28 | 2015-01-13 | Lawrence A. Lynn | System and method for CO2 and oximetry integration |
| US9042952B2 (en) * | 1997-01-27 | 2015-05-26 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
| US20060161071A1 (en) * | 1997-01-27 | 2006-07-20 | Lynn Lawrence A | Time series objectification system and method |
| US9521971B2 (en) | 1997-07-14 | 2016-12-20 | Lawrence A. Lynn | System and method for automatic detection of a plurality of SPO2 time series pattern types |
| US20070191697A1 (en) | 2006-02-10 | 2007-08-16 | Lynn Lawrence A | System and method for SPO2 instability detection and quantification |
| US20060195041A1 (en) | 2002-05-17 | 2006-08-31 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
| US9053222B2 (en) | 2002-05-17 | 2015-06-09 | Lawrence A. Lynn | Patient safety processor |
| US7668579B2 (en) | 2006-02-10 | 2010-02-23 | Lynn Lawrence A | System and method for the detection of physiologic response to stimulation |
| EP3493216A1 (en) * | 2007-11-13 | 2019-06-05 | Oridion Medical 1987 Ltd. | Medical system, apparatus and method |
| US9706965B2 (en) | 2008-05-28 | 2017-07-18 | Oridion Medical 1987 Ltd. | Methods, apparatus and systems for monitoring CO2 |
| GB0818544D0 (en) * | 2008-10-09 | 2008-11-19 | Oxford Biosignals Ltd | Improvements in or relating to multi-parameter monitoring |
| JP5916618B2 (ja) * | 2009-12-19 | 2016-05-11 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | Copd増悪予測システム及び方法 |
| US9408542B1 (en) * | 2010-07-22 | 2016-08-09 | Masimo Corporation | Non-invasive blood pressure measurement system |
| US8554298B2 (en) * | 2010-09-21 | 2013-10-08 | Cividien LP | Medical ventilator with integrated oximeter data |
| EP2441409A1 (en) | 2010-10-12 | 2012-04-18 | Smith&Nephew, Inc. | Medical device |
| EP2785270B1 (en) | 2011-12-03 | 2019-05-01 | Koninklijke Philips N.V. | Automatic depth scrolling and orientation adjustment for semi-automated path planning |
| JP6200430B2 (ja) * | 2011-12-23 | 2017-09-20 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | 圧補助装置を監視し且つ制御する方法及び装置 |
| ES2645646T3 (es) * | 2012-09-07 | 2017-12-07 | The Regents Of The University Of California | Sistema multisensor de vigilancia abdominal |
| US9953453B2 (en) | 2012-11-14 | 2018-04-24 | Lawrence A. Lynn | System for converting biologic particle density data into dynamic images |
| US10354429B2 (en) | 2012-11-14 | 2019-07-16 | Lawrence A. Lynn | Patient storm tracker and visualization processor |
| WO2014134522A1 (en) | 2013-02-28 | 2014-09-04 | Lynn Lawrence A | System and method for generating quaternary images of biologic force propagation and recovery |
| US9737649B2 (en) | 2013-03-14 | 2017-08-22 | Smith & Nephew, Inc. | Systems and methods for applying reduced pressure therapy |
| CN105492035B (zh) | 2013-03-14 | 2019-06-14 | 史密夫和内修有限公司 | 用于应用减压治疗的系统和方法 |
| US10388405B2 (en) | 2013-03-22 | 2019-08-20 | Massachusetts Institute Of Technology | Systems and methods for predicting adverse events and assessing level of sedation during medical procedures |
| EP3033119B1 (en) | 2013-08-13 | 2023-10-11 | Smith & Nephew, Inc. | Systems for applying reduced pressure therapy |
| JP6422653B2 (ja) * | 2014-01-24 | 2018-11-14 | 日本光電工業株式会社 | モニタリング装置 |
| WO2016200244A1 (ko) * | 2015-06-12 | 2016-12-15 | 한국 한의학 연구원 | 호흡가스 분석에 기반하여 미병 분류를 보조하는 컴퓨팅 시스템 및 방법 |
| KR101785788B1 (ko) * | 2015-06-12 | 2017-11-06 | 한국 한의학 연구원 | 호흡가스 분석에 기반하여 미병 분류를 보조하는 컴퓨팅 시스템 및 방법 |
| US20180228399A1 (en) * | 2015-08-11 | 2018-08-16 | Koninklijke Philips N.V. | Capnography with decision support system architecture |
| WO2017027855A1 (en) | 2015-08-12 | 2017-02-16 | Massachusetts Institute Of Technology | Systems and methods for predicting adverse events and assessing level of sedation during medical procedures |
| CN108463160A (zh) * | 2015-12-15 | 2018-08-28 | 呼吸运动公司 | 呼吸量监测评估以在脉搏血氧测定法之前检测呼吸损害并消除假去饱和警报 |
| US20170296094A1 (en) * | 2016-04-15 | 2017-10-19 | Msa Technology, Llc | Breathing apparatus with system-integrated breathing sensor system |
| USD835648S1 (en) | 2016-10-27 | 2018-12-11 | Smith & Nephew, Inc. | Display screen or portion thereof with a graphical user interface for a therapy device |
| EP3568062A1 (en) | 2017-01-16 | 2019-11-20 | Koninklijke Philips N.V. | Physiologic monitoring decision support system combining capnometry and oxygen saturation |
| US12419804B2 (en) * | 2017-01-20 | 2025-09-23 | Physio-Control, Inc. | Systems and methods of managing and evaluating emergency medical procedures |
| US11833296B2 (en) | 2017-06-27 | 2023-12-05 | Nihon Kohden Corporation | Gas monitoring apparatus and system for artificial ventilation |
| US11510591B2 (en) * | 2018-07-11 | 2022-11-29 | Oridion Medical 1987 Ltd. | Capnography systems with indicator lights |
| JP6846584B1 (ja) * | 2020-01-22 | 2021-03-24 | 株式会社汀線科学研究所 | 呼気終末濃度測定装置 |
| KR20230051487A (ko) * | 2020-07-08 | 2023-04-18 | 피셔 앤 페이켈 핼스케어 리미티드 | 호흡 보조와 관련된 개선 사항 |
| JP6990333B1 (ja) * | 2021-05-14 | 2022-02-03 | 株式会社ファンケル | 最適運動強度の推定方法、トレーニング方法、運動指示装置、及び最適運動強度の推定システム |
| KR102781193B1 (ko) * | 2022-06-22 | 2025-03-14 | 주식회사 피맥스 | 의료 영상을 이용한 만성 폐쇄성 폐질환의 정량적 평가 방법 및 장치 |
| KR102771432B1 (ko) * | 2022-06-22 | 2025-02-24 | 주식회사 피맥스 | 의료 영상을 이용한 만성 폐쇄성 폐질환의 정량적 평가 방법 및 장치 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060235324A1 (en) | 1997-01-27 | 2006-10-19 | Lynn Lawrence A | System and method for applying continuous positive airway pressure |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6223064B1 (en) * | 1992-08-19 | 2001-04-24 | Lawrence A. Lynn | Microprocessor system for the simplified diagnosis of sleep apnea |
| US5438983A (en) * | 1993-09-13 | 1995-08-08 | Hewlett-Packard Company | Patient alarm detection using trend vector analysis |
| US20040127800A1 (en) * | 1995-07-06 | 2004-07-01 | Kimball Victor E. | Device for assessing perfusion failure in a patient by measurement of blood flow |
| US6174283B1 (en) * | 1996-05-09 | 2001-01-16 | Albert Einstein Healthcare Network | Apparatus and method for monitoring a system and displaying the status of the system |
| US5769084A (en) * | 1996-07-10 | 1998-06-23 | The United States Of America As Represented By The Secretary Of The Navy | Method and apparatus for diagnosing sleep breathing disorders |
| ATE383814T1 (de) * | 1997-03-17 | 2008-02-15 | Vivometrics Inc | Verfahren zur atmungswellenformanalyse in bezug auf ihren einfluss auf neuromuskuläre atmung |
| US6188407B1 (en) * | 1998-03-04 | 2001-02-13 | Critikon Company, Llc | Reconfigurable user interface for modular patient monitor |
| US7565905B2 (en) * | 1998-06-03 | 2009-07-28 | Scott Laboratories, Inc. | Apparatuses and methods for automatically assessing and monitoring a patient's responsiveness |
| JP2002530133A (ja) * | 1998-11-13 | 2002-09-17 | アーチ・デベロップメント・コーポレーション | 肺結節中の悪性腫瘍検出用システム |
| CA2358446A1 (en) * | 1999-01-21 | 2000-07-27 | Metasensors, Inc. | Non-invasive cardiac output and pulmonary function monitoring using respired gas analysis techniques and physiological modeling |
| US6723055B2 (en) * | 1999-04-23 | 2004-04-20 | Trustees Of Tufts College | System for measuring respiratory function |
| EP1189649B1 (en) * | 1999-06-30 | 2005-06-15 | University Of Florida Research Foundation, Inc. | Ventilator monitor system |
| SE0003531D0 (sv) * | 2000-10-02 | 2000-10-02 | Breas Medical Ab | Auto CPAP |
| EP1349491B1 (en) * | 2000-12-07 | 2013-04-17 | Children's Medical Center Corporation | Automated interpretive medical care system |
| US6533724B2 (en) * | 2001-04-26 | 2003-03-18 | Abiomed, Inc. | Decision analysis system and method for evaluating patient candidacy for a therapeutic procedure |
| GB0113212D0 (en) * | 2001-05-31 | 2001-07-25 | Oxford Biosignals Ltd | Patient condition display |
| PT1455878E (pt) * | 2001-12-06 | 2006-07-31 | Cardinal Health 303 Inc | Sistema de perfusao de farmacos monitorizado por co2 |
| JP4358474B2 (ja) * | 2002-03-07 | 2009-11-04 | 平蔵 徳高 | 健康診断用の自己組織化マップ作成装置及び作成方法 |
| JP3661686B2 (ja) * | 2002-12-19 | 2005-06-15 | 松下電器産業株式会社 | 監視装置 |
| US7006856B2 (en) * | 2003-01-10 | 2006-02-28 | Nellcor Puritan Bennett Incorporated | Signal quality metrics design for qualifying data for a physiological monitor |
| US7639145B2 (en) * | 2003-05-19 | 2009-12-29 | Ge Medical Systems Information Technologies, Inc. | Method and apparatus for communicating an alarm while monitoring |
| WO2005056087A1 (en) * | 2003-12-05 | 2005-06-23 | Cardinal Health 303, Inc. | Patient-controlled analgesia with patient monitoring system |
| WO2005087097A1 (en) * | 2004-03-08 | 2005-09-22 | Masimo Corporation | Physiological parameter system |
| GB0405798D0 (en) * | 2004-03-15 | 2004-04-21 | E San Ltd | Medical data display |
| JP2008526443A (ja) * | 2005-01-13 | 2008-07-24 | ウェルチ・アリン・インコーポレーテッド | 生命兆候モニタ |
| US7680534B2 (en) * | 2005-02-28 | 2010-03-16 | Cardiac Pacemakers, Inc. | Implantable cardiac device with dyspnea measurement |
| US20070010756A1 (en) * | 2005-07-07 | 2007-01-11 | Viertio-Oja Hanna E | Patient monitoring during drug administration |
| EP1904941A4 (en) * | 2005-07-18 | 2009-10-21 | Integralis Ltd | DEVICE, METHOD AND COMPUTER-READABLE CODE FOR PREDICTING THE INCIDENT OF A POTENTIALLY HAZARDOUS DISEASE |
| CN101309716B (zh) * | 2005-09-30 | 2013-03-20 | 纽约大学 | 用于诊断和治疗患者呼吸模式的系统和方法 |
| US8512258B2 (en) * | 2005-11-11 | 2013-08-20 | Exalenz Bioscience Ltd. | Breath test device and method |
| US7766840B2 (en) * | 2005-12-01 | 2010-08-03 | Cardiac Pacemakers, Inc. | Method and system for heart failure status evaluation based on a disordered breathing index |
| WO2007072364A2 (en) * | 2005-12-19 | 2007-06-28 | Koninklijke Philips Electronics, N.V. | Hierarchical real-time patient state indices for patient monitoring |
| WO2007075938A2 (en) * | 2005-12-21 | 2007-07-05 | Everest Biomedical Instruments Co | Integrated portable anesthesia and sedation monitoring apparatus |
| US8170888B2 (en) * | 2006-02-13 | 2012-05-01 | Silverman David G | Method and system for assessing, quantifying, coding and communicating a patient's health and perioperative risk |
| US7941199B2 (en) * | 2006-05-15 | 2011-05-10 | Masimo Laboratories, Inc. | Sepsis monitor |
| US10163174B2 (en) * | 2006-05-30 | 2018-12-25 | The University Of North Carolina At Chapel Hill | Methods, systems, and computer program products for evaluating a patient in a pediatric intensive care unit |
| AU2007308078A1 (en) * | 2006-10-13 | 2008-04-17 | PeraHealth, Inc | System and method for providing a health score for a patient |
| US8852094B2 (en) * | 2006-12-22 | 2014-10-07 | Masimo Corporation | Physiological parameter system |
| US8768718B2 (en) * | 2006-12-27 | 2014-07-01 | Cardiac Pacemakers, Inc. | Between-patient comparisons for risk stratification of future heart failure decompensation |
| US20080230060A1 (en) * | 2007-03-23 | 2008-09-25 | General Electric Company | Setting inspiratory time in mandatory mechanical ventilation based on patient physiology, such as when tidal volume is inspired |
| ATE547044T1 (de) * | 2007-10-11 | 2012-03-15 | Lidco Group Plc | Monitor zur hämodynamischen überwachung |
| EP3493216A1 (en) * | 2007-11-13 | 2019-06-05 | Oridion Medical 1987 Ltd. | Medical system, apparatus and method |
| US20110082357A1 (en) * | 2008-05-28 | 2011-04-07 | Neetour Medical Ltd. | Method and apparatus for co2 evaluation |
-
2007
- 2007-11-13 US US12/742,858 patent/US8414488B2/en active Active
- 2007-11-13 WO PCT/IL2007/001393 patent/WO2009063443A2/en not_active Ceased
- 2007-11-13 EP EP07827366.1A patent/EP2217141B1/en active Active
-
2008
- 2008-06-30 JP JP2010533717A patent/JP5443376B2/ja active Active
-
2010
- 2010-05-13 IL IL205777A patent/IL205777A/en active IP Right Grant
-
2013
- 2013-03-15 US US13/831,721 patent/US20130204099A1/en not_active Abandoned
-
2016
- 2016-07-12 US US15/208,190 patent/US20160345843A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060235324A1 (en) | 1997-01-27 | 2006-10-19 | Lynn Lawrence A | System and method for applying continuous positive airway pressure |
Non-Patent Citations (2)
| Title |
|---|
| KRAUSE BHESS D.R: "Capnography for procedural sedation and analgesia in the emergency department", ANN EMERG MED., vol. 50, no. 2, 2007, pages 172 - 81 |
| See also references of EP2217141A4 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012032501A1 (en) | 2010-09-10 | 2012-03-15 | Mila Group S.R.L. | Portable electromedical device |
| JP2015513724A (ja) * | 2012-02-17 | 2015-05-14 | コーニンクレッカ フィリップス エヌ ヴェ | 急性肺損傷(ali)/急性呼吸窮迫症候群(ards)アセスメント及びモニタリング |
Also Published As
| Publication number | Publication date |
|---|---|
| JP5443376B2 (ja) | 2014-03-19 |
| EP2217141A2 (en) | 2010-08-18 |
| IL205777A0 (en) | 2010-11-30 |
| EP2217141A4 (en) | 2013-04-03 |
| WO2009063443A3 (en) | 2009-09-03 |
| JP2011505177A (ja) | 2011-02-24 |
| IL205777A (en) | 2013-03-24 |
| EP2217141B1 (en) | 2021-03-31 |
| US20130204099A1 (en) | 2013-08-08 |
| US20100317933A1 (en) | 2010-12-16 |
| US20160345843A1 (en) | 2016-12-01 |
| US8414488B2 (en) | 2013-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8414488B2 (en) | Medical system, apparatus and method | |
| EP2229641B1 (en) | Medical system, apparatus and method | |
| US10314515B2 (en) | Capnography device and method | |
| US12121334B2 (en) | Advanced respiratory monitor and system | |
| US10799185B2 (en) | Medical system, apparatus and method | |
| US9370634B2 (en) | Monitoring positive end expiratory pressure with photoplethysmography | |
| EP2584966B1 (en) | Method and system for sleep disturbance analysis | |
| EP1469776A1 (en) | Analysis of sleep apnea | |
| US20190365281A1 (en) | Physiologic monitoring decision support system combining capnometry and oxygen saturation | |
| AU2024278561A1 (en) | Advanced respiratory monitor and system | |
| US20260108172A1 (en) | Advanced Respiratory Monitor and System | |
| CA3032574C (en) | Advanced respiratory monitor and system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07827366 Country of ref document: EP Kind code of ref document: A2 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 205777 Country of ref document: IL |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2007827366 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 12742858 Country of ref document: US |